PolyPid Ltd. Calls Extraordinary General Meeting for Feb 4, 2026

Ticker: PYPD · Form: 6-K · Filed: Dec 31, 2025 · CIK: 1611842

Polypid Ltd. 6-K Filing Summary
FieldDetail
CompanyPolypid Ltd. (PYPD)
Form Type6-K
Filed DateDec 31, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, proxy-statement, corporate-governance

TL;DR

PolyPid calling shareholder meeting Feb 4, 2026 - vote matters!

AI Summary

PolyPid Ltd. has filed a Form 6-K on December 31, 2025, to report its Notice of Meeting, Proxy Statement, and Proxy Card for an Extraordinary General Meeting of Shareholders. This meeting is scheduled for February 4, 2026, and shareholders of record as of January 5, 2026, are eligible to vote.

Why It Matters

This filing indicates upcoming shareholder decisions and potential corporate actions that could impact the company's future direction and stock value.

Risk Assessment

Risk Level: low — The filing is procedural, announcing a shareholder meeting, and does not contain new financial or operational risks.

Key Players & Entities

  • PolyPid Ltd. (company) — Registrant
  • February 4, 2026 (date) — Extraordinary General Meeting date
  • January 5, 2026 (date) — Record date for shareholder eligibility

FAQ

What is the purpose of the Extraordinary General Meeting?

The meeting is to discuss and vote on matters presented in the Notice of Meeting, Proxy Statement, and Proxy Card.

When is the record date for shareholders to be eligible to vote?

Shareholders of record at the close of business on January 5, 2026, are entitled to notice of and to vote at the meeting.

What type of shares does PolyPid Ltd. have?

PolyPid Ltd. has ordinary shares with no par value.

What form is being filed?

A Form 6-K, Report of Foreign Private Issuer.

Where is PolyPid Ltd. headquartered?

PolyPid Ltd. is headquartered at 18 Hasivim Street, Petach Tikva, Israel.

Filing Stats: 366 words · 1 min read · ~1 pages · Grade level 9.2 · Accepted 2025-12-31 16:01:17

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. POLYPID LTD. Date: December 31, 2025 By: /s/ Dikla Czaczkes Akselbrad Name: Dikla Czaczkes Akselbrad Title: Chief Executive Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.